These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
|
For
the quarterly period ended June 30,
2010
|
|
|
or
|
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
|
For
the transition period from ________ to
________
|
|
National Research
Corporation
|
|
(Exact
name of Registrant as specified in its
charter)
|
|
Wisconsin
|
47-0634000
|
|
(I.R.S.
Employer
|
|
|
incorporation
or organization)
|
Identification
No.)
|
|
1245 “Q” Street,
Lincoln,
Nebraska 68508
|
|
(Address
of principal executive offices) (Zip
Code)
|
|
(402)
475-2525
|
|
(Registrant’s
telephone number, including area
code)
|
|
Page No.
|
|||
|
PART
I.
|
FINANCIAL
INFORMATION
|
||
|
Item
1.
|
Financial
Statements
|
||
|
Condensed
Consolidated Balance Sheets
|
4
|
||
|
Condensed
Consolidated Statements of Income
|
5
|
||
|
Condensed
Consolidated Statements of Cash Flows
|
6
|
||
|
Condensed
Notes to Consolidated Financial Statements
|
7-13
|
||
|
Item
2.
|
Management’s
Discussion and Analysis of
Financial
Condition and Results of Operations
|
13-18
|
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures About
Market
Risk
|
18
|
|
|
Item
4.
|
Controls
and Procedures
|
18
|
|
|
PART
II.
|
OTHER
INFORMATION
|
||
|
Item
1A.
|
Risk
Factors
|
18
|
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and
Use
of Proceeds
|
18
|
|
|
Item
6.
|
Exhibits
|
19
|
|
|
Signatures
|
20
|
||
|
Exhibit
Index
|
21
|
||
|
|
·
|
The
possibility of non-renewal of the Company’s performance tracking
contracts;
|
|
|
·
|
The
Company’s ability to compete in its markets, which are highly competitive,
and the possibility of increased price pressure and
expenses;
|
|
|
·
|
The
effects of the economic downturn;
|
|
|
·
|
The
possibility of consolidation in the healthcare
industry;
|
|
|
·
|
The
impact of federal healthcare reform legislation or other regulatory
changes;
|
|
|
·
|
The
Company’s ability to retain its limited number of key
clients;
|
|
|
·
|
The
Company’s ability to manage its growth, including identifying acquisition
candidates and effectively integrating acquired
companies;
|
|
|
·
|
The
Company’s ability to collect the data on which its business
relies;
|
|
|
·
|
The
Company’s ability to attract and retain key managers and other
personnel;
|
|
|
·
|
The
possibility that the Company’s intellectual property and other proprietary
information technology could be copied or independently developed by its
competitors;
|
|
|
·
|
Errors
in, or dissatisfaction with, performance tracking and other surveys
provided by the Company;
|
|
|
·
|
Regulatory
developments; and
|
|
|
·
|
The
factors set forth under the caption “Risk Factors” in Part I, Item 1A of
the Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2009, as such section may be updated by Part II,
Item 1A of the Company’s subsequently filed Quarterly Reports on Form 10-Q
(including this Report).
|
|
|
June
30,
2010
(Unaudited)
|
December
31,
2009
|
||||||
|
Assets
|
||||||||
|
Current
assets:
|
||||||||
|
Cash
and cash equivalents
|
$ | 7,236 | $ | 2,512 | ||||
|
Trade
accounts receivable, less allowance for doubtful accounts of $310 and $279
in 2010 and 2009, respectively
|
7,902 | 5,214 | ||||||
|
Unbilled
revenue
|
1,248 | 1,173 | ||||||
|
Prepaid
expenses and other
|
1,451 | 1,864 | ||||||
|
Recoverable
income taxes
|
1,325 | 803 | ||||||
|
Deferred
income taxes
|
201 | 98 | ||||||
|
Total
current assets
|
19,363 | 11,664 | ||||||
|
Property
and equipment, net
|
13,031 | 13,975 | ||||||
|
Intangible
assets, net
|
6,307 | 6,883 | ||||||
|
Goodwill
|
39,927 | 39,924 | ||||||
|
Other
|
196 | 53 | ||||||
|
Total
assets
|
$ | 78,824 | $ | 72,499 | ||||
|
Liabilities and
Shareholders’ Equity
|
||||||||
|
Current
liabilities:
|
||||||||
|
Current
portion of note payable
|
$ | 819 | $ | 816 | ||||
|
Accounts
payable
|
564 | 598 | ||||||
|
Accrued
wages, bonus and profit sharing
|
2,281 | 1,926 | ||||||
|
Accrued
expenses
|
1,166 | 848 | ||||||
|
Deferred
revenue
|
15,909 | 11,907 | ||||||
|
Total
current liabilities
|
20,739 | 16,095 | ||||||
|
Note
payable, net of current portion
|
6,149 | 6,903 | ||||||
|
Deferred
income taxes
|
5,306 | 5,126 | ||||||
|
Deferred
revenue
|
253 | 204 | ||||||
|
Other
long term liabilities
|
9 | -- | ||||||
|
Total
liabilities
|
32,456 | 28,328 | ||||||
|
Shareholders’
equity:
|
||||||||
|
Common
stock, $.001 par value; authorized 20,000,000 shares, issued 8,029,282 in
2010 and 8,018,044 in 2009, outstanding 6,653,001 in 2010 and 6,662,111 in
2009
|
8 | 8 | ||||||
|
Additional
paid-in capital
|
28,274 | 27,871 | ||||||
|
Retained
earnings
|
40,165 | 37,905 | ||||||
|
Accumulated
other comprehensive income
|
766 | 769 | ||||||
|
Treasury
stock, at cost; 1,376,281 shares in 2010 and 1,355,933 shares in
2009
|
(22,845 | ) | (22,382 | ) | ||||
|
Total
shareholders’ equity
|
46,368 | 44,171 | ||||||
|
Total
liabilities and shareholders’ equity
|
$ | 78,824 | $ | 72,499 | ||||
|
Three
months ended
June 30,
|
Six
months ended
June 30, |
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Revenue
|
$ | 14,139 | $ | 13,594 | $ | 31,509 | $ | 30,334 | ||||||||
|
Operating
expenses:
|
||||||||||||||||
|
Direct
expenses
|
5,877 | 6,114 | 12,333 | 13,242 | ||||||||||||
|
Selling,
general and administrative
|
4,545 | 3,887 | 9,014 | 8,016 | ||||||||||||
|
Depreciation
and amortization
|
1,059 | 891 | 2,157 | 2,001 | ||||||||||||
|
Total operating
expenses
|
11,481 | 10,892 | 23,504 | 23,259 | ||||||||||||
|
Operating income
|
2,658 | 2,702 | 8,005 | 7,075 | ||||||||||||
|
Other
income (expense):
|
||||||||||||||||
|
Interest
income
|
2 | - | 3 | 1 | ||||||||||||
|
Interest
expense
|
(93 | ) | (85 | ) | (191 | ) | (223 | ) | ||||||||
|
Other, net
|
49 | (98 | ) | 6 | (57 | ) | ||||||||||
|
Total other income
(expense)
|
(42 | ) | (183 | ) | (182 | ) | (279 | ) | ||||||||
|
Income before income
taxes
|
2,616 | 2,519 | 7,823 | 6,796 | ||||||||||||
|
Provision
for income taxes
|
956 | 910 | 3,034 | 2,537 | ||||||||||||
|
Net income
|
$ | 1,660 | $ | 1,609 | $ | 4,789 | $ | 4,259 | ||||||||
|
Net
income per share – basic
|
$ | .25 | $ | .24 | $ | .72 | $ | .64 | ||||||||
|
Net
income per share – diluted
|
$ | .25 | $ | .24 | $ | .71 | $ | .63 | ||||||||
|
Weighted
average shares and share equivalents outstanding – basic
|
6,634 | 6,637 | 6,637 | 6,635 | ||||||||||||
|
Weighted
average shares and share equivalents outstanding – diluted
|
6,732 | 6,734 | 6,724 | 6,720 | ||||||||||||
|
Six
months ended
|
||||||||
|
June
30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cash
flows from operating activities:
|
||||||||
|
Net
income
|
$ | 4,789 | $ | 4,259 | ||||
|
Adjustments
to reconcile net income to net cash
|
||||||||
|
provided
by operating activities:
|
||||||||
|
Depreciation
and amortization
|
2,157 | 2,001 | ||||||
|
Deferred
income taxes
|
73 | 539 | ||||||
|
Loss
(gain) on disposal of property and equipment
|
1 | -- | ||||||
|
Non-cash
share-based compensation expense
|
368 | 384 | ||||||
|
Tax
benefit from exercise of stock options
|
4 | -- | ||||||
|
Net
changes in assets and liabilities:
|
||||||||
|
Trade
accounts receivable
|
(2,686 | ) | (855 | ) | ||||
|
Unbilled
revenue
|
(74 | ) | (310 | ) | ||||
|
Prepaid
expenses and other
|
221 | 123 | ||||||
|
Accounts
payable
|
(57 | ) | 187 | |||||
|
Accrued
expenses, wages, bonuses and profit sharing
|
830 | 233 | ||||||
|
Income
taxes recoverable and payable
|
(522 | ) | (115 | ) | ||||
|
Deferred
revenue
|
4,050 | 1,198 | ||||||
|
Net
cash provided by operating activities
|
9,154 | 7,644 | ||||||
|
Cash
flows from investing activities:
|
||||||||
|
Purchases
of property and equipment
|
(588 | ) | (2,083 | ) | ||||
|
Payment
of acquisition earn-out obligation
|
(172 | ) | -- | |||||
|
Net
cash used in investing activities
|
(760 | ) | (2,083 | ) | ||||
|
Cash
flows from financing activities:
|
||||||||
|
Proceeds
from notes payable
|
-- | 3,741 | ||||||
|
Payments
on notes payable
|
(690 | ) | (7,887 | ) | ||||
|
Payments
on other long term liabilities
|
(17 | ) | -- | |||||
|
Purchases
of treasury stock
|
(399 | ) | -- | |||||
|
Proceeds
from exercise of stock options
|
31 | -- | ||||||
|
Common
stock withheld from vested restricted shares for payroll
tax withholdings
|
(64 | ) | (73 | ) | ||||
|
Excess
tax benefit from share-based compensation
|
5 | 4 | ||||||
|
Payment
of dividends on common stock
|
(2,529 | ) | (2,131 | ) | ||||
|
Net
cash used in financing activities
|
(3,663 | ) | (6,346 | ) | ||||
|
Effect
of exchange rate changes on cash
|
(7 | ) | 80 | |||||
|
Increase
(decrease) in cash and cash equivalents
|
4,724 | (705 | ) | |||||
|
Cash
and cash equivalents at beginning of period
|
2,512 | 1,109 | ||||||
|
Cash
and cash equivalents at end of period
|
$ | 7,236 | $ | 404 | ||||
|
Supplemental
disclosure of cash paid for:
|
||||||||
|
Interest
expense
|
$ | 191 | $ | 258 | ||||
|
Income
taxes
|
$ | 4,158 | $ | 2,053 | ||||
|
1.
|
BASIS
OF CONSOLIDATION AND PRESENTATION
|
|
Level 1
|
Level 2
|
Level 3
|
||||||||||
|
(In
thousands)
|
||||||||||||
|
Money
Market Funds
|
$ | 237 | $ | -- | $ | -- | ||||||
|
Three
months ended
June 30,
|
Six
months ended
June
30,
|
|||||||||||||||
|
(in
thousands)
|
(in
thousands)
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Net
income
|
$ | 1,660 | $ | 1,609 | $ | 4,789 | $ | 4,259 | ||||||||
|
Other
comprehensive income (loss):
|
||||||||||||||||
|
Foreign
currency translation
|
(187 | ) | 350 | (3 | ) | 259 | ||||||||||
|
Total
other comprehensive income (loss)
|
(187 | ) | 350 | (3 | ) | 259 | ||||||||||
|
Comprehensive
income
|
$ | 1,473 | $ | 1,959 | $ | 4,786 | $ | 4,518 | ||||||||
|
Number
of
Options
|
Weighted
Average Exercise
Price
|
Weighted
Average Remaining Contractual
Terms
Years
|
Aggregate
Intrinsic
Value
|
|||||||||||||
|
Outstanding
at December 31, 2009
|
577,822 | $ | 22.06 | |||||||||||||
|
Granted
|
122,647 | $ | 23.58 | |||||||||||||
|
Exercised
|
(2,000 | ) | $ | 15.46 | ||||||||||||
|
Outstanding
at June 30, 2010
|
698,469 | $ | 22.34 | 5.96 | $ | 15,603,797 | ||||||||||
|
Exercisable
at June 30, 2010
|
349,319 | $ | 20.73 | 6.13 | $ | 7,241,383 | ||||||||||
|
2010
|
2009
|
||
|
Expected
dividend yield at date of grant
|
2.86
to 3.09%
|
1.93
to 2.35%
|
|
|
Expected
stock price volatility
|
31.20
to 27.00%
|
24.20
to 30.20%
|
|
|
Risk-free
interest rate
|
2.13
to 2.56%
|
1.55
to 2.15%
|
|
|
Expected
life of options (in years)
|
4.00
to 6.00
|
4.00
to 6.00
|
|
Shares
Outstanding
|
Weighted
Average Grant Date Fair
Value Per
Share
|
|||||||
|
Outstanding
at December 31, 2009
|
21,956 | $ | 21.68 | |||||
|
Granted
|
9,238 | $ | 21.65 | |||||
|
Vested
|
(8,558 | ) | $ | 23.37 | ||||
|
Forfeited
|
-- | -- | ||||||
|
Outstanding
at June 30, 2010
|
22,636 | $ | 21.03 | |||||
|
(In
thousands)
|
||||
|
Balance
as of December 31, 2009
|
$ | 39,924 | ||
|
Foreign
currency translation
|
3 | |||
|
Balance
as of June 30, 2010
|
$ | 39,927 | ||
|
June 30, 2010
|
December 31, 2009
|
|||||||
|
(In
thousands)
|
||||||||
|
Non-amortizing
other intangible assets:
|
||||||||
|
Trade
name
|
1,191 | 1,191 | ||||||
|
Amortizing
other intangible assets:
|
||||||||
|
Customer
related intangibles
|
8,174 | 8,174 | ||||||
|
Trade
name
|
1,572 | 1,572 | ||||||
|
Total
other intangible assets
|
10,937 | 10,937 | ||||||
|
Less
accumulated amortization
|
(4,630 | ) | (4,054 | ) | ||||
|
Other
intangible assets, net
|
$ | 6,307 | $ | 6,883 | ||||
|
June 30, 2010
|
December 31, 2009
|
|||||||
|
(In
thousands)
|
||||||||
|
Property
and equipment
|
$ | 25,514 | $ | 29,105 | ||||
|
Accumulated
depreciation
|
(12,483 | ) | (15,130 | ) | ||||
|
Property
and equipment, net
|
$ | 13,031 | $ | 13,975 | ||||
|
Three
months ended
|
Six
months ended
|
|||||||||||||||
|
June 30,
(in
thousands)
|
June 30,
(in
thousands)
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Weighted
average shares and share equivalents - basic
|
6,634 | 6,637 | 6,637 | 6,635 | ||||||||||||
|
Weighted
average dilutive effect of options
|
86 | 84 | 74 | 74 | ||||||||||||
|
Weighted
average dilutive effect of restricted stock
|
12 | 13 | 13 | 11 | ||||||||||||
|
Weighted
average shares and share equivalents - dilutive
|
6,732 | 6,734 | 6,724 | 6,720 | ||||||||||||
|
Three
months ended
|
Six
months ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Revenue:
|
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||
|
Operating
expenses:
|
||||||||||||||||
|
Direct
expenses
|
41.6 | 45.0 | 39.1 | 43.7 | ||||||||||||
|
Selling,
general and administrative
|
32.1 | 28.6 | 28.6 | 26.4 | ||||||||||||
|
Depreciation
and amortization
|
7.5 | 6.5 | 6.9 | 6.6 | ||||||||||||
|
Total
operating expenses
|
81.2 | 80.1 | 74.6 | 76.7 | ||||||||||||
|
Operating
income
|
18.8 | % | 19.9 | % | 25.4 | % | 23.3 | % | ||||||||
|
Period
|
Total
Number of Shares
Purchased
|
Average
Price
Paid
per
Share
|
Total
Number of Shares Purchased as Part of Publicly Announced
Plans or Programs
|
Maximum
Number of Shares that May Yet Be Purchased Under the
Plans or Programs
|
||||||||||||
|
April
1 – April 30, 2010
|
0 | $ | 0.00 | 0 | 275,317 | |||||||||||
|
May
1 – May 31, 2010
|
6,600 | $ | 24.65 | 6,600 | 268,717 | |||||||||||
|
June
1 – June 30, 2010
|
0 | $ | 0.00 | 0 | 268,717 | |||||||||||
| NATIONAL RESEARCH CORPORATION | |||
| Date: August 13, 2010 |
By:
|
/s/ Michael D. Hays | |
| Michael D. Hays | |||
| President and Chief Executive Officer (Principal Executive Officer) | |||
|
Date:
August 13, 2010
|
By:
|
/s/ Patrick E. Beans | |
|
Patrick
E. Beans
Vice
President, Treasurer, Secretary and
Chief
Financial Officer (Principal
Financial
and Accounting Officer)
|
|||
|
(10)
|
National
Research Corporation 2004 Director Stock Plan, as
amended.
|
|
(31.1)
|
Certification
by the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a)
under the Securities Exchange Act of
1934.
|
|
(31.2)
|
Certification
by the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a)
under the Securities Exchange Act of
1934.
|
|
(32)
|
Written
Statement of the Chief Executive Officer and Chief Financial Officer
pursuant to 18 U.S.C. Section 1350.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|